Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Richmond

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|September 2, 2011
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancerAnita L Sabichi, J Jack Lee, H Barton Grossman, et al.
Journal of the National Cancer Institute|July 2, 2025
A summary of the national cancer institute think tank on advancing gastric cancer preventionM Constanza Camargo, Christian C Abnet, Jeremy L Davis, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFPTimothy R Morgan, Kathryn Osann, Teodoro Bottiglieri, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 6, 2011
Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasmsSteven Lipkin, John Lee, David Imagawa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2019
Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative ModelingAmir-Houshang Omidvari, Ayman Ali, William D Hazelton, et al.
Journal of the National Cancer Institute|December 1, 2010
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trialCraig A Elmets, Jaye L Viner, Alice P Pentland, et al.
Plos One|April 5, 2018
Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trialRamesh K Wali, Laura Bianchi, Sonia Kupfer, et al.
Gastroenterology|May 11, 2021
The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness AnalysisAmir-Houshang Omidvari, William D Hazelton, Brianna N Lauren, et al.
Digestive Diseases and Sciences|February 11, 2025
Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication with Radiofrequency AblationRobert S Bresalier, Nicholas J Shaheen, Mike Hernandez, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 18, 2026
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 LevelsShehnaz K Hussain, Walid S Ayoub, Marcia Cruz-Correa, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cancer Prevention Research (Philadelphia, Pa.)|September 2, 2011
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancerAnita L Sabichi, J Jack Lee, H Barton Grossman, et al.
Journal of the National Cancer Institute|July 2, 2025
A summary of the national cancer institute think tank on advancing gastric cancer preventionM Constanza Camargo, Christian C Abnet, Jeremy L Davis, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFPTimothy R Morgan, Kathryn Osann, Teodoro Bottiglieri, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 6, 2011
Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasmsSteven Lipkin, John Lee, David Imagawa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2019
Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative ModelingAmir-Houshang Omidvari, Ayman Ali, William D Hazelton, et al.
Journal of the National Cancer Institute|December 1, 2010
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trialCraig A Elmets, Jaye L Viner, Alice P Pentland, et al.
Plos One|April 5, 2018
Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trialRamesh K Wali, Laura Bianchi, Sonia Kupfer, et al.
Gastroenterology|May 11, 2021
The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness AnalysisAmir-Houshang Omidvari, William D Hazelton, Brianna N Lauren, et al.
Digestive Diseases and Sciences|February 11, 2025
Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication with Radiofrequency AblationRobert S Bresalier, Nicholas J Shaheen, Mike Hernandez, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 18, 2026
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 LevelsShehnaz K Hussain, Walid S Ayoub, Marcia Cruz-Correa, et al.
Pageof 4